International Journal of Gynecological Cancer

The exploding worldwide cancer burden: the impact of cancer on women
pp. 1-11(11)
Authors: Wilson C.M.; Tobin S.; Young R.C.

Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology
pp. 12-22(11)
Author: Kim E.E.

The relative importance of surgical training and laboratory research in a gynecologic oncology fellowship
pp. 23-34(12)
Authors: Eisenkop S.M.; Spirtos N.M.

Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum
pp. 35-41(7)
Authors: Look M.; Chang D.; Sugarbaker P.H.

Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer
pp. 42-50(9)
Authors: Brockbank E.C.; Ind T.E.J.; Barton D.P.J.; Shepherd J.H.; Gore M.E.; A'Hern R.; Bridges J.E.

The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer
pp. 51-56(6)
Authors: Ayhan A.; A. Al R.; Baykal C.; Demirtas E.; Yüce K.

Comparison of hydrosonography and transvaginal ultrasonography in the detection of intracavitary pathologies in women with abnormal uterine bleeding
pp. 57-63(7)
Authors: Guven M.A.; Bese T.; Demirkiran F.

Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer
pp. 64-75(12)
Authors: Santin A.D.; Bellone S.; Palmieri M.; Bossini B.; Cane' S.; Bignotti E.; Roman J.J.; Cannon M.J.; Pecorelli S.

Mechanisms of reversal of adriamycin resistance in human ovarian carcinoma cell line by ultrasound
pp. 76-81(6)
Authors: Yu T.; Huang X.; Hu K.; Bai J.; Wang Z.

Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor and vascular endothelial growth factor
pp. 82-88(7)
Authors: Sönmezer M.; Güngör M.; Ensari A.; OrtaÇ F.

Sulfatides in ovarian tumors: clinicopathological correlates
pp. 89-93(5)
Authors: Makhlouf A.M.; Fathalla M.M.; Zakhary M.A.; Makarem M.H.

Vulvar soft tissue tumors
pp. 94-99(6)
Authors: Behranwala K.A.; Latifaj B.; Blake P.; Barton D.P.J.; Shepherd J.H.; Thomas J.M.

Unique use of botulinum toxin to decrease adductor tone and allow surgical excision of vulvar carcinoma
pp. 100-103(4)
Authors: Guo Y.; Shin K.

The risk of nodal metastasis in early adenocarcinoma of the uterine cervix
pp. 104-109(6)
Authors: Balega J.; Michael H.; Hurteau J.; Moore D.H.; Santiesteban J.; Sutton G.P.; Look K.Y.

Chemoradiation for primary invasive squamous carcinoma of the vagina
pp. 110-117(8)
Authors: Dalrymple J.L.; Russell A.H.; Lee S.W.; Scudder S.A.; Leiserowitz G.S.; Kinney W.K.; Smith L.H.

Gene–gene and gene–environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer
pp. 118-125(8)
Authors: Lee J.E.; Lee S.J.; Namkoong S.E.; Um S.J.; Sull J.W.; Jee S.H.; You Y.K.; Park J.S.

Correlation between histological criteria and human papillomavirus presence based on PCR assay in cervical biopsies
pp. 126-132(7)
Authors: Salvia P.N.D.; Bergo S.M.; Bonesso-Sabadini P.I.P.; Tagliarini E.B.; Hackel C.; De Angelo Andrade L.A.L.

Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival
pp. 133-137(5)
Authors: Geisler J.P.; Geisler H.E.; Manahan K.J.; Miller G.A.; Wiemann M.C.; Zhou Z.; Crabtree W.

Nuclear size, shape, and density in endometrial carcinoma: relationship to survival at over 5 years of follow-up. Does analyzing only cells occupying the G₀–G₁ peak add useful information?
pp. 138-144(7)
Authors: Miller J.; Geisler J.P.; Manahan K.J.; Geisler H.E.; Miller G.A.; Zhou Z.; Wiemann M.C.; Crabtree W.

Inability of immunohistochemistry to predict clinical outcomes of endometrial cancer patients
pp. 145-151(7)
Authors: Gossett D.R.; Alo P.; Bristow R.E.; Galati M.; Kyshtoobayeva A.; Fruehauf J.; Montz F.J.

Comparison of hepatocyte growth factor levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts
pp. 152-156(5)
Authors: Baykal C.; Demirta E.; Al A.; Ayhan A.; Yüce K.; Tulunay G.; Köse M.F.

The role of neurosurgery in the treatment of cerebral metastases from choriocarcinoma: a report of two cases
pp. 157-161(5)
Authors: Semple P.L.; Denny L.; Coughlan M.; Soeters R.; Van Wijk L.

Malignant peritoneal mesothelioma in a 76-year-old woman with a history of asbestos fiber ingestion
pp. 162-165(4)
Authors: Van Kesteren P.; Bulten J.; Schijf C.; Boonstra H.; Massuger L.

Primary fallopian tube carcinoma presenting with a sinus in the posterior portion of cervix
pp. 166-168(3)
Authors: Khan Y.; Haq A.N.; NASAR R.

Synchronous mucinous adenocarcinoma of the endometrium and mucinous cystadenoma of bilateral ovaries presenting during fertility therapy
pp. 169-171(3)
Authors: Gotoh T.; Hayashi N.; Takeda S.; Itoyama S.; Takano M.; Kikuchi Y.

Rapid growth of myxoid leiomyosarcoma of the vulva during pregnancy: a case report
pp. 172-175(4)
Authors: Di Gilio A.R.; Cormio G.; Resta L.; Carriero C.; Loizzi V.; Parisi A.M.; Selvaggi L.

Extensive subcutaneous metastasis from squamous cell carcinoma of the cervix in patient with HIV
pp. 176-177(2)
Authors: Joseph B.; Chiramana H.

Letter to the Editor
pp. 178-179(2)
Authors: Snijders-Keilholz A.; Ansink A.C.; Burger C.W.

Parametrial involvement as a risk factor
pp. 179-180(2)
Author: Ohara K.

The Cancer Chemotherapy Handbook
pp. 181-181(1)
Authors: Fischer D.S.; Tish Knobf M.; Durivage H.J.; Beaulieu N.J.